Good levels to buy TRVN
Updated
Very bullish for NASDAQ:TRVN in the long term.
- High demand product with blockbuster drug good for opiod crisis.
- Potential replacement for morphine, no real competitor
- Partnership with Syneos for sales
- Potential buyout
Good levels to buy at 2.50 and 2.33
Should see rise towards next quarter earnings.
Long term PTs
TP1 - $5
TP2 - $15
TP3 - $30
- High demand product with blockbuster drug good for opiod crisis.
- Potential replacement for morphine, no real competitor
- Partnership with Syneos for sales
- Potential buyout
Good levels to buy at 2.50 and 2.33
Should see rise towards next quarter earnings.
Long term PTs
TP1 - $5
TP2 - $15
TP3 - $30
Note
holdNote
Falling wedge pattern in the short term and an ascending triangle on the mid term.
Continue hold towards next quarter earnings in March
Note
Seems to breaking out of the falling wedge
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.